Trial
NCT07547436
A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Non-cystic Fibrosis Bronchiectasis
Intervention
SAR445399
Why stopped
The pause is for strategic business reasons to facilitate internal portfolio review.
The pause is not due to any concerns with patient safety, with program benefit/risk, or with trial integrity.
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-29